We are live on ! Find out more
BCC

Bridge City Capital Portfolio holdings

AUM $361M
1-Year Est. Return 38.29%
This Fund
S&P 500
This Quarter Est. Return
+0.07%
1 Year Est. Return
+38.29%
3 Year Est. Return
+76.88%
5 Year Est. Return
+81.43%
10 Year Est. Return
AUM
$298M
AUM Growth
+$23M
Cap. Flow
+$28M
Cap. Flow %
9.4%
Top 10 Hldgs %
23.54%
Holding
113
New
3
Increased
101
Reduced
6
Closed
3

Top Buys

Rank Stock Value
1
FN icon
Fabrinet
FN
+$2.29M
2
THRM icon
Gentherm
THRM
+$2.19M
3
ENSG icon
The Ensign Group
ENSG
+$1.7M
4
TTEK icon
Tetra Tech
TTEK
+$1.58M
5
AIN icon
Albany International
AIN
+$1.52M

Sector Composition

Rank Sector Weight
1 Technology 25.23%
2 Healthcare 21.48%
3 Industrials 20.4%
4 Consumer Discretionary 11.52%
5 Financials 5.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENSG icon
1
The Ensign Group
ENSG
$10B
$8.88M 2.99%
71,820
+14,249
+25% +$1.7M
FIX icon
2
Comfort Systems
FIX
$60.4B
$8.18M 2.75%
26,888
+3,070
+13% +$976K
TTEK icon
3
Tetra Tech
TTEK
$8.25B
$8.14M 2.73%
198,945
+38,685
+24% +$1.58M
COHR icon
4
Coherent
COHR
$55.5B
$7.85M 2.64%
108,270
+20,447
+23% +$1.23M
LMAT icon
5
LeMaitre Vascular
LMAT
$2.18B
$7.42M 2.49%
90,206
+17,002
+23% +$1.25M
GMED icon
6
Globus Medical
GMED
$10.4B
$6.46M 2.17%
94,360
+18,648
+25% +$1.11M
ATEN icon
7
A10 Networks
ATEN
$2.49B
$5.92M 1.99%
427,645
+80,485
+23% +$1.15M
STRL icon
8
Sterling Infrastructure
STRL
$20.6B
$5.87M 1.97%
49,595
-1,311
-3% -$150K
ACLS icon
9
Axcelis
ACLS
$4.1B
$5.67M 1.91%
39,904
+8,782
+28% +$1.01M
MEDP icon
10
Medpace
MEDP
$17B
$5.66M 1.9%
13,740
-4,816
-26% -$1.91M
MTSI icon
11
MACOM Technology Solutions
MTSI
$20.4B
$5.42M 1.82%
48,589
+9,173
+23% +$935K
RBC icon
12
RBC Bearings
RBC
$18.9B
$5.18M 1.74%
19,202
+3,697
+24% +$993K
UFPI icon
13
UFP Industries
UFPI
$4.97B
$5.06M 1.7%
45,171
+8,925
+25% +$1.04M
PFGC icon
14
Performance Food Group
PFGC
$17.5B
$5.04M 1.69%
76,171
+14,732
+24% +$1.03M
THRM icon
15
Gentherm
THRM
$1.35B
$4.86M 1.63%
98,617
+42,461
+76% +$2.19M
GBCI icon
16
Glacier Bancorp
GBCI
$6.56B
$4.86M 1.63%
130,175
+25,730
+25% +$956K
USPH icon
17
US Physical Therapy
USPH
$1.14B
$4.48M 1.5%
48,450
+11,252
+30% +$1.14M
LAD icon
18
Lithia Motors
LAD
$7.79B
$4.31M 1.45%
17,082
+3,387
+25% +$887K
AIN icon
19
Albany International
AIN
$2.14B
$4.25M 1.43%
50,307
+17,386
+53% +$1.52M
CBZ icon
20
CBIZ
CBZ
$2.27B
$4.22M 1.42%
56,958
+11,177
+24% +$845K
DIOD icon
21
Diodes
DIOD
$4.04B
$4.21M 1.42%
58,536
+21,085
+56% +$1.51M
EXLS icon
22
EXL Service
EXLS
$4.23B
$4.2M 1.41%
133,798
+26,669
+25% +$801K
NEOG icon
23
Neogen
NEOG
$2.06B
$4.19M 1.41%
267,829
+90,625
+51% +$1.26M
WHD icon
24
Cactus
WHD
$3.88B
$3.68M 1.24%
69,727
+137
+0.2% +$6.98K
ADUS icon
25
Addus HomeCare
ADUS
$2.14B
$3.66M 1.23%
31,481
+482
+2% +$51.6K

Similar funds

Bridge City Capital's Q2 2024 Portfolio in Review

As of Q2 2024, Bridge City Capital held 113 positions worth $298M, up 8.4% from $275M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Bridge City Capital deployed $28M of net new capital in Q2 2024, opening 3 new positions and adding to 101 existing holdings. Its largest new stake was Fabrinet: 10,799 shares worth $2.64M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Onto Innovation, an estimated $2.41M trimmed.

  • Bridge City Capital's largest Q2 2024 buy was Fabrinet: 10,799 shares worth $2.64M.
  • Bridge City Capital added most to Gentherm in Q2 2024, an estimated $2.19M increase.
  • Bridge City Capital's biggest Q2 2024 reduction was Onto Innovation, cutting an estimated $2.41M.
  • Bridge City Capital fully exited Phibro Animal Health in Q2 2024, selling an estimated $1.78M.
  • Bridge City Capital's ten largest holdings make up 24% of its $298M portfolio in Q2 2024.
  • Bridge City Capital opened 3 new positions and closed 3 in Q2 2024.
  • Bridge City Capital's portfolio value rose 8.4% quarter-over-quarter to $298M.

Based on Bridge City Capital's 13F filing for Q2 2024, filed 13 Aug 2024.